LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.69
-0.02 (-0.19%)
At close: Aug 21, 2026, 4:00 PM EDT
7.63
-0.06 (-0.78%)
After-hours: Aug 21, 2026, 7:30 PM EDT
LeonaBio Employees
LeonaBio had 19 employees as of December 31, 2025. The number of employees decreased by 7 or -26.92% compared to the previous year.
Employees
19
Change (1Y)
-7
Growth (1Y)
-26.92%
Revenue / Employee
n/a
Profits / Employee
-$7,445,000
Market Cap
72.41M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | -7 | -26.92% | 19 | 0 |
| Dec 31, 2024 | 26 | -41 | -61.19% | 26 | 0 |
| Dec 31, 2023 | 67 | 3 | 4.69% | 65 | 2 |
| Dec 31, 2022 | 64 | 29 | 82.86% | 63 | 1 |
| Dec 31, 2021 | 35 | 13 | 59.09% | 34 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| XBiotech | 87 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Cardiff Oncology | 31 |
| Spero Therapeutics | 25 |
| iBio, Inc. | 20 |
LONA News
- 4 days ago - LeonaBio price target lowered to $15 from $16 at Mizuho - TheFly
- 6 days ago - LeonaBio price target lowered to $17 from $18 at Citizens - TheFly
- 9 days ago - LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 9 days ago - LeonaBio Quarterly report: Q2 2026 - Filings
- 9 days ago - LeonaBio Earnings release: Q2 2026 - Filings
- 11 days ago - LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer - GlobeNewsWire
- 2 months ago - LeonaBio Transcript: AGM 2026 - Transcripts
- 2 months ago - Athena Gold Provides Exploration Update from Excelsior Springs, Nevada - Newsfile Corp